Your browser doesn't support javascript.
[Consideration on implementation of co-administration of Seasonal Influenza and COVID-19 vaccines during pandemic in China].
Zhang, T; Bai, X F; Wang, W; Liu, X X; Zhang, X X; Wang, D Y; Zhang, S B; Chen, Z P; He, H Q; Huang, Z Y; Xu, A Q; Peng, Z B; Feng, L Z; Yu, W Z; Feng, Zijian.
  • Zhang T; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100730, China.
  • Bai XF; Institute of Public Health Service Information, Sichuan Center for Disease Control and Prevention, Chengdu 610041, China.
  • Wang W; Department of Immunization Planning, Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China.
  • Liu XX; Department of Expanded Program of Immunization, Jinan Center for Disease Control and Prevention, Jinan 250021, China.
  • Zhang XX; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
  • Wang DY; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Zhang SB; Shaanxi Province Center for Disease Control and Prevention, Xi'an 710054, China.
  • Chen ZP; Zhejiang Center for Disease Control and Prevention, Hangzhou 310051, China.
  • He HQ; Department of Immunization, Zhejiang Center for Disease Control and Prevention, Hangzhou 310051, China.
  • Huang ZY; Department of Immunization Program, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China.
  • Xu AQ; Shandong Provincial Center for Disease Control and Prevention, Jinan 250014, China.
  • Peng ZB; Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Feng LZ; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100730, China.
  • Yu WZ; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
  • Feng Z; Chinese Preventive Medicine Association, Beijing 100021, China.
Zhonghua Yu Fang Yi Xue Za Zhi ; 56(2): 103-107, 2022 Feb 06.
Article in Chinese | MEDLINE | ID: covidwho-1600048
ABSTRACT
Influenza is an infectious respiratory disease caused by the influenza viruses. Older people, infants and people with underlying medical conditions could have a higher risk of severe influenza symptoms and complications. The co-infection of Coronavirus Diseases 2019 (COVID-19) with influenza viruses could lead to the complication of prevention, diagnosis, control, treatment, and recovery of COVID-19. Influenza vaccine and COVID-19 vaccine overlapped in target populations, vaccination time, and inoculation units. Although there was insufficient evidence on the immunogenicity and safety of co-administration of influenza vaccine and COVID-19 vaccine, World Health Organization and some countries recommended co-administration of inactivated influenza vaccine and COVID-19 vaccine. This review summarized domestic and international vaccination policies and research progress, and put forward corresponding suggestions in order to provide scientific support for the formulation of vaccination strategy on seasonal influenza vaccine and COVID-19 vaccine.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Aged / Humans / Infant Country/Region as subject: Asia Language: Chinese Journal: Zhonghua Yu Fang Yi Xue Za Zhi Year: 2022 Document Type: Article Affiliation country: Cma.j.cn112150-20211203-01117

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Aged / Humans / Infant Country/Region as subject: Asia Language: Chinese Journal: Zhonghua Yu Fang Yi Xue Za Zhi Year: 2022 Document Type: Article Affiliation country: Cma.j.cn112150-20211203-01117